跳至主要内容
临床试验/ISRCTN49514912
ISRCTN49514912进行中(未招募)1 期

Detection of metastatic axillary sentinel lymph nodes using ultrafast, super-resolution, dual-contrast enhanced ultrasound imaging in patients with breast cancer

Maidstone and Tunbridge Wells NHS Trust0 个研究点目标入组 60 人开始时间: 2021年8月3日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Provision of written informed consent
  • 2. Histologically confirmed invasive carcinoma of the breast with planned primary surgical treatment
  • 3. Female aged 18 to 80 years
  • 4. In the Investigator’s opinion, adhering to the trial recommendations and governance

排除标准

  • 1. Previous ipsilateral breast cancer treated with radiotherapy or chemotherapy
  • 2. Participant who is pregnant, lactating or planning pregnancy during the course of the study
  • 3. Allergy to ultrasound contrast
  • 4. Cannot provide consent
  • 5. Inflammatory or locally advanced breast cancer
  • 6. Patients with right to left cardiac shunts
  • 7. Severe pulmonary hypertension
  • 8. Adult respiratory distress syndrome
  • 9. Uncontrolled hypertension
  • 10. Heart failure
  • 11. Renal failure
  • 12. Recent thromboembolism
  • 13. Hypercoagulation disorder

研究者

相似试验